Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures
Launched by MUHAMMAD AYOUB · Oct 22, 2022
Trial Information
Current as of October 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best surgical options for children with cerebral palsy who have a dislocated hip and are unable to walk. Researchers want to compare three different procedures: one that aims to reconstruct the hip joint, one that focuses on relieving pain and improving function, and another that involves changing the angle of the thigh bone to help with sitting and balance. The goal is to see which procedure works best and has fewer complications for these children.
To participate in this study, children need to have a dislocated hip that has not been treated before and must be classified as non-ambulatory, meaning they cannot walk (specifically, those in levels IV and V of the Gross Motor Function Classification System). Participants will be monitored after their surgery to assess pain relief and improvements in their ability to sit and move comfortably. This trial is important because it aims to provide clearer guidance on how to best help children with this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Lesion: neglected deformed dislocated hip (Deformed head Group B, C, and D according to Rutz classification modified from MCPHCS )
- • Non-ambulatory: as defined by GMFCS level IV and V
- Exclusion Criteria:
- • Ambulatory patients
- • patients underwent any previous hip bony procedures.
- • Non-deformed Femoral head Group A according to Rutz classification
- • Neuromuscular hip dislocation other than cp.
About Muhammad Ayoub
Muhammad Ayoub is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ensuring compliance with regulatory standards and ethical practices, Ayoub oversees the development and execution of clinical trials across various therapeutic areas. Leveraging extensive expertise in clinical operations and collaboration with leading healthcare professionals, the organization aims to contribute meaningful insights to the medical community while prioritizing participant safety and data integrity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Abbasia, Egypt
Patients applied
Trial Officials
Mootaz Thakeb, MD
Study Chair
Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials